PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.013